Phase I Study PK Study With OXP005 and Naprosyn
Clinical trial NCT02351024 · COMPLETED
Trial details
- NCT number
- NCT02351024
- Sponsor
- Oxford Pharmascience Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2015-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.